New Challenges in the Use of Nanomedicine in Cancer Therapy

The Use of Radiation Therapy in Cancer Treatment

Oncology & Radiation Therapy for Cancer: Clinical Principles and Applications

Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study

Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches

A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Enhancing chemotherapy for colorectal cancer: EGFR-conjugated ferritin nanocages for targeted doxorubicin delivery

Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial

Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges